Article Information
vol. 58 no. suppl 65
Published By
Print ISSN
Online ISSN
History
- Published online November 25, 2021.
Copyright & Usage
Copyright ©the authors 2021
Author Information
- Huib A.M. Kerstjens1⇑,
- Richard Van Zyl-Smit2,
- Kenneth Chapman3,
- Jorge Maspero4,
- Motoi Hosoe5,
- Ana-Maria Tanase5,
- David Lawrence5,
- Abhijit Pethe6,
- Xu Shu6,
- Karen Mezzi5 and
- Peter D'Andrea6
- 1Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands
- 2Division of Pulmonology and UCT Lung Institute, University of Cape Town, Cape Town, South Africa
- 3Division of Respiratory Medicine, Department of Medicine, University of Toronto, Toronto, Canada
- 4Fundación CIDEA (Centro de Investigación de Enfermedades Alérgicas y Respiratorias), Buenos Aires, Argentina
- 5Novartis Pharma AG, Basel, Switzerland
- 6Novartis Pharmaceuticals Corporation, East Hanover, NJ, United States of America
- Huib A.M. Kerstjens, Department of Pulmonology, University of Groningen, University Medical Center Groningen, and Groningen Research Institute for Asthma and COPD, Groningen, Netherlands. E-mail: h.a.m.kerstjens{at}umcg.nl
Article usage
Altmetrics
Vol 58 Issue suppl 65
Table of Contents
Efficacy of mometasone/indacaterol/glycopyrronium (MF/IND/GLY) versus fluticasone/salmeterol (FLU/SAL) in ex-smoker and never smoker patients with inadequately controlled asthma: Post hoc analysis of IRIDIUM study
